Resources from the same session
133O - Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial
Presenter: Vivianne Tjan-Heijnen
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA13 - Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial
Presenter: Marleen Kok
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Webcast
LBA14 - Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials
Presenter: Oleg Gluz
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
134O - Dose-dense adjuvant chemotherapy in early-stage breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella (GIM)
Presenter: Lucia Del Mastro
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA14 and 134O
Presenter: Peter Dubsky
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Webcast